Fresenius Medical Care AG (LON:0H9X)

Market Cap	9.64B -18.3%
Revenue (ttm)	17.15B +2.1%
Net Income	626.88M +9.0%
EPS	2.13 +8.6%
Shares Out	n/a
PE Ratio	15.38
Forward PE	10.96
Dividend	1.21 (3.01%)
Ex-Dividend Date	May 23, 2025

Volume	232,361
Average Volume	119,030
Open	40.38
Previous Close	40.27
Day's Range	39.96 - 40.42
52-Week Range	35.70 - 54.00
Beta	0.94
RSI	58.15
Earnings Date	Feb 24, 2026

About Fresenius Medical Care AG

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospital...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1996
• Employees: 109,916
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0H9X

Financial Performance

In 2024, Fresenius Medical Care AG's revenue was 19.34 billion, a decrease of -0.61% compared to the previous year's 19.45 billion. Earnings were 537.91 million, an increase of 7.80%.

Financial numbers in EUR